CDC Investigating Reports of Illnesses from Botox Injections
According to the U.S. Centers for Disease Control and Prevention (CDC), as of Apr. 12, 2024, a total of 18 people from nine states have reported adverse reactions after receiving Botox injections from unlicensed or untrained individuals or in “non-healthcare” settings, such as homes and medi-spas. The states reporting adverse reactions to Botox include Colorado, […]
FDA Removes Social Media Posts Against Ivermectin, Settles Lawsuit
The U.S. Food and Drug Administration (FDA) and the U.S. Department of Health and Human Services (HHS) have agreed to remove social media posts and web pages cautioning the public not to take the FDA-approved drug Ivermectin to treat COVID-19 symptoms. The move comes as part of lawsuit settlement. In 2022, three doctors, Drs. Mary […]
MRI Contrast Agent Gadolinium May Deposit and Retain in the Brain
Magnetic resonance images (MRIs) are used to investigate or diagnose conditions that affect soft tissue in the body such as brain tumors, brain disorders, torn ligaments, or spinal issues. They are so common that nearly 40 million MRIs are performed annually in the United States. But questions and debate remain regarding the safety of the […]
Texas Man and Dairy Cattle Test Positive for Bird Flu
A man in Texas has tested positive for the H5N1 bird flu after direct exposure to infected dairy cattle. While this is the second recent case of bird flu identified in humans in the United States, it is the first time the disease has been found in dairy cattle.1 The first case of H5N1 in […]
Drinking Water Fluoridation: Is It Safe?
Experts have called the practice of adding the chemical compound fluoride to drinking water as “safe and effective” for decades. The U.S. Centers for Disease Control and Prevention (CDC) has named it one of the top 10 greatest health achievements of the 20th century. For years, those who have opposed it have been called “anti-science” […]
CDC Pushes Pfizer’s Pentavalent Meningococcal Vaccine
On Oct. 20, 2023, Pfizer, Inc. announced that the U.S. Food and Drug Administration (FDA) approved its new pentavalent meningococcal vaccine, Penbraya, which targets five meningococcal serogroups (A, B, C, W and Y) that most commonly cause meningococcal disease in adolescents and young adults 10-25 years old. Penbraya, is recommended to be given in two […]